ARK Genomic Revolution ETF Rating $30.04 +6.43 (+27.21%) Closing price 10/3/2025 03:59 PM EasternExtended Trading$30.12 +0.09 (+0.30%) As of 10/3/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.55Holdings in ARKG have an aggregate rating of Moderate Buy based on 342 analyst ratings issued in the past year covering 25 companies (91.1% of the portfolio).ARKG Aggregate Price Target$30.04High Prediction$30.04Average Prediction$30.04Low Prediction$30.04Holdings in ARKG have an aggregate price target of $30.04 and a range of $30.04 to $30.04 covering 25 companies (91.1% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.07%TEMTempus AI$91.66+2.6%1.6106 of 5 stars2.43$71.83 -21.6%14Positive News9.80%CRSPCRISPR Therapeutics$67.74-7.0%1.9264 of 5 stars2.42$71.50 5.6%19News Coverage5.09%TWSTTwist Bioscience$31.07+1.3%3.7033 of 5 stars2.55$48.90 57.4%11Analyst Forecast4.82%RXRXRecursion Pharmaceuticals$5.49-0.5%2.2946 of 5 stars2.17$7.25 32.1%64.61%PSNLPersonalis$7.34+8.4%2.8882 of 5 stars2.67$7.42 1.0%6Positive News4.53%NTLAIntellia Therapeutics$19.96-2.3%4.3717 of 5 stars2.45$27.39 37.2%204.22%GHGuardant Health$62.84+2.2%3.7235 of 5 stars2.96$65.75 4.6%24Analyst Forecast3.94%BEAMBeam Therapeutics$25.75+0.6%2.8881 of 5 stars2.93$46.40 80.2%143.90%ADPTAdaptive Biotechnologies$14.38+1.0%3.1573 of 5 stars2.70$13.22 -8.1%10Analyst Forecast3.81%NTRANatera$167.35+4.5%2.9851 of 5 stars2.90$192.88 15.3%20Positive NewsInsider Trade3.50%IONSIonis Pharmaceuticals$69.15+1.1%3.3481 of 5 stars2.78$73.88 6.8%18Trending NewsInsider Trade3.48%VCYTVeracyte$36.00+1.0%3.3517 of 5 stars2.55$40.90 13.6%113.36%SDGRSchrodinger$20.59-4.0%3.3813 of 5 stars2.38$26.57 29.1%8News CoverageAnalyst Downgrade3.24%ARCTArcturus Therapeutics$22.56+3.1%2.6041 of 5 stars2.78$50.57 124.2%9High Trading Volume3.21%TXG10x Genomics$12.75+3.6%3.6835 of 5 stars2.25$13.65 7.1%16News CoverageAnalyst Upgrade3.08%ILMNIllumina$102.12+2.8%4.751 of 5 stars2.15$123.33 20.8%20News CoveragePositive NewsAnalyst Forecast3.01%ABSIAbsci$3.38-4.8%3.169 of 5 stars2.71$7.98 136.0%7News CoverageAnalyst ForecastOptions Volume2.74%CDNACareDx$15.19+2.4%4.3696 of 5 stars2.38$25.50 67.9%8Analyst Upgrade2.32%PRMEPrime Medicine$6.32-5.2%2.9458 of 5 stars2.75$8.92 41.1%81.48%MASS908 Devices$9.07+3.7%2.0242 of 5 stars2.80$8.00 -11.8%51.24%PACBPacific Biosciences of California$1.49+4.2%2.1251 of 5 stars2.25$1.90 27.5%81.19%NRIXNurix Therapeutics$9.38+3.3%2.1025 of 5 stars2.76$29.07 209.9%17Upcoming Earnings1.19%AMGNAmgen$297.89+0.2%4.5657 of 5 stars2.29$309.70 4.0%21Positive NewsAnalyst Upgrade1.17%EXASExact Sciences$56.72+0.9%4.5592 of 5 stars2.83$68.52 20.8%24Analyst Forecast1.07%INCYIncyte$86.85+0.7%4.5213 of 5 stars2.28$83.64 -3.7%18Positive NewsAnalyst Upgrade This page (BATS:ARKG) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
